{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:00:04Z","timestamp":1788238804852,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Cancer Centre South, Lund, Sweden"},{"name":"Governmental Funding of Clinical Research within the National Health Services"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The use of patient-reported outcome measures (PROM) can be beneficial in several ways. However, presentations of PROM data from individuals living with, through, or beyond cancer are scarce in the existing scientific literature, and challenges in presenting and interpreting PROM data may be an explanation. Our overall aim was to describe aspects of wellbeing in individuals living with current or previous cancer, 1\u20132 and 5\u20136 years after diagnosis. We also aimed to identify vulnerable subgroups of individuals and to facilitate the interpretation of PROM data by combining different presentation forms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>Adults in the Southern healthcare region in Sweden with invasive breast, prostate, lung, or colorectal cancer diagnosed 1\u20132 or 5\u20136 years ago were invited to a survey using the European Organisation for Research and Treatment of Cancer (EORTC) instrument QLQ-C30 (C30). We analyzed subgroups of respondents using scale scores, clinically anchored problem ranges, and Quality-Adjusted Life Years weights. Moreover, we compared our C30 scores to Swedish general population reference values, EORTC diagnose-specific reference values, and other similar cancer studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 2,131 individuals responded (26% response rate). The results demonstrate consistent differences in C30 scale scores, where respondents with several comorbidities, younger age, and lung and colorectal cancer diagnoses had poorer scores. Respondents within problem ranges were consistent with the results on scale scores. Quality-Adjusted Life Years weights displayed a generally similar pattern. Our respondents showed no differences on C30 scales compared to the Swedish general population and recent similar studies. There were some differences compared to diagnose-specific reference values and some older similar studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Aspects of wellbeing varied between subgroups, suggesting potential to develop care for certain patient groups with poorer scores, i.e. the younger age groups and in those with several comorbidities, and individuals diagnosed with lung cancer and colorectal cancer. However, individuals who lived 1\u20132 or 5\u20136 years after cancer diagnosis experienced no difference in wellbeing than published results from the Swedish general population. Our different ways of presenting PROM show similar results overall but serve to elucidate different aspects which may contribute to the practice of presenting and interpreting PROM data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41687-026-01115-z","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:13:16Z","timestamp":1780481596000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient-reported outcomes and health-related quality of life in individuals living with, through, and beyond cancer in Sweden: a cross-sectional study"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6292-7002","authenticated-orcid":false,"given":"Sixten","family":"Borg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-1866","authenticated-orcid":false,"given":"Linn","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7677-7452","authenticated-orcid":false,"given":"Lars","family":"Garpenhag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Calling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3957-3266","authenticated-orcid":false,"given":"Anna-Maria","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"issue":"1","key":"1115_CR1","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12913-022-07657-4","volume":"22","author":"R Ruseckaite","year":"2022","unstructured":"Ruseckaite R, Maharaj AD, Dean J, Krysinska K, Ackerman IN, Brennan AL et al (2022) Preliminary development of recommendations for the inclusion of patient-reported outcome measures in clinical quality registries. BMC Health Serv Res 22(1):276","journal-title":"BMC Health Serv Res"},{"issue":"34 Suppl 1","key":"1115_CR2","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/intqhc\/mzac001","volume":"34","author":"J Mainz","year":"2022","unstructured":"Mainz J, Kristensen S, Roe D (2022) The power of the patient\u2019s voice in the modern health care system. Int J Qual Health Care 34(34 Suppl 1):ii1\u2013ii2","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"1115_CR3","doi-asserted-by":"publisher","first-page":"e0267030","DOI":"10.1371\/journal.pone.0267030","volume":"17","author":"L Carfora","year":"2022","unstructured":"Carfora L, Foley CM, Hagi-Diakou P, Lesty PJ, Sandstrom ML, Ramsey I et al (2022) Patients\u2019 experiences and perspectives of patient-reported outcome measures in clinical care: A systematic review and qualitative meta-synthesis. PLoS ONE 17(4):e0267030","journal-title":"PLoS ONE"},{"issue":"5","key":"1115_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2217\/cer-2015-0014","volume":"5","author":"I Porter","year":"2016","unstructured":"Porter I, Goncalves-Bradley D, Ricci-Cabello I, Gibbons C, Gangannagaripalli J, Fitzpatrick R et al (2016) Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities. J Comp Eff Res 5(5):507\u2013519","journal-title":"J Comp Eff Res"},{"issue":"12","key":"1115_CR5","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.3390\/ijerph111212223","volume":"11","author":"S Borg","year":"2014","unstructured":"Borg S, Palaszewski B, Gerdtham UG, Fredrik O, Roos P, Gudbjornsdottir S (2014) Patient-reported outcome measures and risk factors in a quality registry: a basis for more patient-centered diabetes care in Sweden. Int J Environ Res Public Health 11(12):12223\u201312246","journal-title":"Int J Environ Res Public Health"},{"key":"1115_CR6","doi-asserted-by":"publisher","unstructured":"Kendir C, Tran S, van den Berg M, de Bienassis K (2025) PROMoting quality of care through patient reported outcome measures (PROMs). Systematic collection of PROMs for quality improvement and assurance in 38 countries. https:\/\/doi.org\/10.1787\/c17bb968-en","DOI":"10.1787\/c17bb968-en"},{"key":"1115_CR7","unstructured":"Drummond MF, O\u2019Brien BJ, Stoddart GL, Torrance GW (1997) Methods for the economic evaluation of health care programmes (2nd Ed). Oxford University Press, Oxford"},{"key":"1115_CR8","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12916-015-0449-6","volume":"13","author":"LM van Vliet","year":"2015","unstructured":"van Vliet LM, Harding R, Bausewein C, Payne S, Higginson IJ, Euroimpact (2015) How should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design. BMC Med 13:263","journal-title":"BMC Med"},{"key":"1115_CR9","unstructured":"Regionalt cancercentrum syd (2022) Cancerplan f\u00f6r S\u00f6dra sjukv\u00e5rdsregionen 2023\u20132025. Version 20221201. [Swedish. Cancer plan for the Southern Healthcare region 2023\u20132025]. Online. https:\/\/www.cancercentrum.se. Accessed 2023-02-11"},{"key":"1115_CR10","doi-asserted-by":"crossref","unstructured":"Taylor A, Davies A (2026) Group PRe-D. e-Delphi study on European expert views about cancer survivor and related terminologies. J Cancer Surviv","DOI":"10.1007\/s11764-026-01972-z"},{"issue":"5","key":"1115_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365\u2013376","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1115_CR12","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/S0022-5347(01)64247-2","volume":"158","author":"G Borghede","year":"1997","unstructured":"Borghede G, Karlsson J, Sullivan M (1997) Quality of life in patients with prostatic cancer: results from a Swedish population study. J Urol 158(4):1477\u20131485 discussion 86","journal-title":"J Urol"},{"issue":"6","key":"1115_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1023\/B:QURE.0000031342.11869.2f","volume":"13","author":"B Thome","year":"2004","unstructured":"Thome B, Dykes AK, Hallberg IR (2004) Quality of life in old people with and without cancer. Qual Life Res 13(6):1067\u20131080","journal-title":"Qual Life Res"},{"issue":"6","key":"1115_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/pon.3147","volume":"22","author":"A Wikman","year":"2013","unstructured":"Wikman A, Djarv T, Johar A, Lagergren P (2013) Health-related quality of life does not differ between short-term, long-term and very long-term cancer survivors in the Swedish general population. Psychooncology 22(6):1369\u20131374","journal-title":"Psychooncology"},{"issue":"2","key":"1115_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/codi.16332","volume":"25","author":"A Sjovall","year":"2023","unstructured":"Sjovall A, Lagergren P, Johar A, Buchli C (2023) Quality of life and patient reported symptoms after colorectal cancer in a Swedish population. Colorectal Dis 25(2):191\u2013201","journal-title":"Colorectal Dis"},{"issue":"6","key":"1115_CR16","doi-asserted-by":"publisher","first-page":"4370","DOI":"10.3390\/curroncol29060349","volume":"29","author":"CJG van den Hurk","year":"2022","unstructured":"van den Hurk CJG, Mols F, Eicher M, Chan RJ, Becker A, Geleijnse G et al (2022) A Narrative Review on the Collection and Use of Electronic Patient-Reported Outcomes in Cancer Survivorship Care with Emphasis on Symptom Monitoring. Curr Oncol 29(6):4370\u20134385","journal-title":"Curr Oncol"},{"issue":"4","key":"1115_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/028418600750013384","volume":"39","author":"H Michelson","year":"2000","unstructured":"Michelson H, Bolund C, Nilsson B, Brandberg Y (2000) Health-related quality of life measured by the EORTC QLQ-C30\u2013reference values from a large sample of Swedish population. Acta Oncol 39(4):477\u2013484","journal-title":"Acta Oncol"},{"issue":"1","key":"1115_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/0284186X.2011.614636","volume":"51","author":"M Derogar","year":"2012","unstructured":"Derogar M, van der Schaaf M, Lagergren P (2012) Reference values for the EORTC QLQ-C30 quality of life questionnaire in a random sample of the Swedish population. Acta Oncol 51(1):10\u201316","journal-title":"Acta Oncol"},{"key":"1115_CR19","unstructured":"Scott NW, Fayers P, Aaronson NK, Bottomley A, de Graeff A, Groenvold M et al (2008) EORTC QLQ-C30 reference values manual. (2nd ed.). EORTC Quality of Life Group. http:\/\/groups.eortc.be\/qol\/downloads\/reference_values_manual2008.pdf"},{"key":"1115_CR20","doi-asserted-by":"crossref","unstructured":"Wintner L, Sztankay M, Giesinger J, Aaronson N, Bottomley A, Velikova G et al (2016) Quality of life group manual for the use of EORTC measures in daily clinical practice. European Organisation for Research and Treatment of Cancer: Brussels 2016. Online. https:\/\/qol.eortc.org. Accessed 4 May 2021","DOI":"10.1016\/j.ejca.2016.08.024"},{"key":"1115_CR21","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A et al (2001) The EORTC QLQ-C30 scoring manual (3rd Edition). European Organisation for Research and Treatment of Cancer: Brussels"},{"issue":"2","key":"1115_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1586\/erp.11.9","volume":"11","author":"MT King","year":"2011","unstructured":"King MT (2011) A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11(2):171\u2013184","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"1115_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM (2011) Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol 29(1):89\u201396","journal-title":"J Clin Oncol"},{"key":"1115_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jclinepi.2019.10.003","volume":"118","author":"JM Giesinger","year":"2020","unstructured":"Giesinger JM, Loth FLC, Aaronson NK, Arraras JI, Caocci G, Efficace F et al (2020) Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research. J Clin Epidemiol 118:1\u20138","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"1115_CR25","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/0272989X15587497","volume":"35","author":"TA Young","year":"2015","unstructured":"Young TA, Mukuria C, Rowen D, Brazier JE, Longworth L (2015) Mapping Functions in Health-Related Quality of Life: Mapping from Two Cancer-Specific Health-Related Quality-of-Life Instruments to EQ-5D-3L. Med Decis Mak 35(7):912\u2013926","journal-title":"Med Decis Mak"},{"issue":"2","key":"1115_CR26","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11136-013-0496-4","volume":"23","author":"K Burstrom","year":"2014","unstructured":"Burstrom K, Sun S, Gerdtham UG, Henriksson M, Johannesson M, Levin LA et al (2014) Swedish experience-based value sets for EQ-5D health states. Qual Life Res 23(2):431\u2013442","journal-title":"Qual Life Res"},{"key":"1115_CR27","unstructured":"The Dental and Pharmaceutical Benefits Agency (TLV) (2017) TLVAR 2017:1. Tandv\u00e5rds- och l\u00e4kemedelsverkets allm\u00e4nna r\u00e5d. \u00c4ndring i Tandv\u00e5rds- och l\u00e4kemedelsf\u00f6rm\u00e5nsverkets allm\u00e4nna r\u00e5d (TLVAR 2003:2) om ekonomiska utv\u00e4rderingar. [Swedish: General guidance on economic evaluations.]. Online. https:\/\/www.tlv.se. Accessed 2025-08-11"},{"key":"1115_CR28","unstructured":"The Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) (2023) Utv\u00e4rdering av insatser i h\u00e4lso- och sjukv\u00e5rden och socialtj\u00e4nsten: En metodbok. [Swedish: Evaluation of interventions in healthcare and social services: methods]. Stockholm: Statens beredning f\u00f6r medicinsk och social utv\u00e4rdering (SBU). On line: https:\/\/www.sbu.se\/metodbok. Accessed 2025-08-11"},{"key":"1115_CR29","unstructured":"The National Board of Health and Welfare (2019) The swedish cancer register. online https:\/\/www.socialstyrelsense\/en\/statistics-and-data\/registers\/alla-register\/swedish-cancer-register\/ Accessed 10 July 2019"},{"issue":"9836","key":"1115_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380(9836):37\u201343","journal-title":"Lancet"},{"issue":"2","key":"1115_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf 42(2):377\u2013381","journal-title":"J Biomed Inf"},{"key":"1115_CR32","unstructured":"R Core Team (2025) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.R-project.org\/"},{"key":"1115_CR33","unstructured":"Posit Team (2025) RStudio: integrated development environment for R. Posit Software, PBC, Boston MA http:\/\/www.posit.co\/"},{"issue":"14","key":"1115_CR34","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1016\/S0959-8049(00)00186-6","volume":"36","author":"K Bjordal","year":"2000","unstructured":"Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D et al (2000) A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 36(14):1796\u20131807","journal-title":"Eur J Cancer"},{"key":"1115_CR35","volume-title":"Quality of life: the assessment, analysis, and reporting of patient-reported outcomes","author":"P Fayers","year":"2016","unstructured":"Fayers P, Machin D (2016) Quality of life: the assessment, analysis, and reporting of patient-reported outcomes, Third edn. John Wiley & Sons Inc., Chichester, West Sussex, UK; Hoboken, NJ","edition":"Third"},{"issue":"13","key":"1115_CR36","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.ejca.2008.05.008","volume":"44","author":"K Cocks","year":"2008","unstructured":"Cocks K, King MT, Velikova G, Fayers PM, Brown JM (2008) Quality, interpretation and presentation of European Organisation for Research and Treatment of Cancer quality of life questionnaire core 30 data in randomised controlled trials. Eur J Cancer 44(13):1793\u20131798","journal-title":"Eur J Cancer"},{"issue":"2","key":"1115_CR37","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jclinepi.2009.03.016","volume":"63","author":"G Kemmler","year":"2010","unstructured":"Kemmler G, Zabernigg A, Gattringer K, Rumpold G, Giesinger J, Sperner-Unterweger B et al (2010) A new approach to combining clinical relevance and statistical significance for evaluation of quality of life changes in the individual patient. J Clin Epidemiol 63(2):171\u2013179","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"1115_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139\u2013144","journal-title":"J Clin Oncol"},{"issue":"19","key":"1115_CR39","doi-asserted-by":"publisher","first-page":"20150","DOI":"10.1002\/cam4.6596","volume":"12","author":"AKG Levinsen","year":"2023","unstructured":"Levinsen AKG, Kjaer TK, Thygesen LC, Maltesen T, Jakobsen E, Gogenur I et al (2023) Social inequality in cancer survivorship: Educational differences in health-related quality of life among 27,857 cancer survivors in Denmark. Cancer Med 12(19):20150\u201320162","journal-title":"Cancer Med"},{"key":"1115_CR40","unstructured":"Manly BFJ (1986) Multivariate statistical methods: a primer. London; New York, Chapman and Hall"},{"issue":"1","key":"1115_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12888-017-1277-3","volume":"17","author":"S Calling","year":"2017","unstructured":"Calling S, Midlov P, Johansson SE, Sundquist K, Sundquist J (2017) Longitudinal trends in self-reported anxiety. Effects of age and birth cohort during 25 years. BMC Psychiatry 17(1):119","journal-title":"BMC Psychiatry"},{"issue":"3","key":"1115_CR42","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00038-015-0658-y","volume":"60","author":"SE Johansson","year":"2015","unstructured":"Johansson SE, Midlov P, Sundquist J, Sundquist K, Calling S (2015) Longitudinal trends in good self-rated health: effects of age and birth cohort in a 25-year follow-up study in Sweden. Int J Public Health 60(3):363\u2013373","journal-title":"Int J Public Health"},{"key":"1115_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2340\/1651-226X.2024.35094","volume":"63","author":"ALV Johansson","year":"2024","unstructured":"Johansson ALV, Konig SM, Laronningen S, Engholm G, Kroman N, Sepp\u00e4 K et al (2024) Have the recent advancements in cancer therapy and survival benefitted patients of all age groups across the Nordic countries? NORDCAN survival analyses 2002\u20132021. Acta Oncol 63:179\u2013191","journal-title":"Acta Oncol"},{"issue":"4","key":"1115_CR44","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s11764-021-01160-1","volume":"17","author":"M van Leeuwen","year":"2023","unstructured":"van Leeuwen M, Kieffer JM, Young TE, Annunziata MA, Arndt V, Arraras JI et al (2023) Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire. J Cancer Surviv 17(4):1111\u20131130","journal-title":"J Cancer Surviv"},{"issue":"11","key":"1115_CR45","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan P (1997) Modeling valuations for EuroQol health states. Med Care 35(11):1095\u20131108","journal-title":"Med Care"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-026-01115-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-026-01115-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:46:48Z","timestamp":1780681608000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41687-026-01115-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1115"],"URL":"https:\/\/doi.org\/10.1186\/s41687-026-01115-z","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Swedish Ethical Review Authority (file no. 2022-05569-01). Informed consent was obtained digitally from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}